126 related articles for article (PubMed ID: 32727491)
21. Mucosal IgG and IgA responses to human papillomavirus type 16 capsid proteins in HPV16-infected women without visible pathology.
Rocha-Zavaleta L; Pereira-Suarez AL; Yescas G; Cruz-Mimiaga RM; Garcia-Carranca A; Cruz-Talonia F
Viral Immunol; 2003; 16(2):159-68. PubMed ID: 12828867
[TBL] [Abstract][Full Text] [Related]
22. Serological study in Tunisian cervical cancer patients.
Achour M; Kochbati L; Zeghal D; Kahla S; Maalej M; Zouari F; Oueslati R
Pathol Biol (Paris); 2009 Jul; 57(5):415-9. PubMed ID: 18586408
[TBL] [Abstract][Full Text] [Related]
23. Association of human papillomavirus type 16 and its genetic variants with cervical lesion in Korea.
Park JS; Shin S; Kim EC; Kim JE; Kim YB; Oh S; Roh EY; Yoon JH
APMIS; 2016 Nov; 124(11):950-957. PubMed ID: 27546189
[TBL] [Abstract][Full Text] [Related]
24. Nasal immunization of mice with peptide having a cross-neutralization epitope on minor capsid protein L2 of human papillomavirus type 16 elicit systemic and mucosal antibodies.
Kawana K; Kawana Y; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T
Vaccine; 2001 Jan; 19(11-12):1496-502. PubMed ID: 11163673
[TBL] [Abstract][Full Text] [Related]
25. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
[TBL] [Abstract][Full Text] [Related]
26. Displaying 31RG-1 peptide on the surface of HPV16 L1 by use of a human papillomavirus chimeric virus-like particle induces cross-neutralizing antibody responses in mice.
Chen X; Zhang T; Liu H; Hao Y; Liao G; Xu X
Hum Vaccin Immunother; 2018; 14(8):2025-2033. PubMed ID: 29683766
[TBL] [Abstract][Full Text] [Related]
27. Association between PD-L1 and HPV status and the prognostic value for HPV treatment in premalignant cervical lesion patients.
Yang-Chun F; Zhen-Zhen C; Yan-Chun H; Xiu-Min M
Medicine (Baltimore); 2017 Jun; 96(25):e7270. PubMed ID: 28640134
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus genotypes among females in Mexico: a study from the Mexican institute for social security.
Salcedo M; Pina-Sanchez P; Vallejo-Ruiz V; Monroy-Garcia A; Aguilar-Lemarroy A; Cortes-Gutierrez EI; Santos-Lopez G; Montoya-Fuentes H; Grijalva R; Madrid-Marina V; Apresa-Garcia T; Hernandez DM; Jave-Suarez LF; Romero P; Poot A; Salgado E; Ramos-Gonzalez P; Gonzalez-Hernandez R; Canton JC; Jimenez-Aranda L; Parra-Melquiadez M; Paniagua L; Mendoza M; Arreola H; Villegas V; Torres-Poveda K; Bahena-Roman M; Gonzalez-Yebra B; Taniguchi K; Rodea C; Mantilla-Morales A; Mora-Garcia ML; Velazquez-Velazquez CK; Cordova-Uscanga C; Peralta R; Lopez-Romero R; Marrero D; Bandala C; Reyes-Leyva J; Furuya ME; Almeida E; Galvan ME; Grijalva I
Asian Pac J Cancer Prev; 2014; 15(23):10061-6. PubMed ID: 25556426
[TBL] [Abstract][Full Text] [Related]
29. A papillomavirus-like particle (VLP) vaccine displaying HPV16 L2 epitopes induces cross-neutralizing antibodies to HPV11.
Slupetzky K; Gambhira R; Culp TD; Shafti-Keramat S; Schellenbacher C; Christensen ND; Roden RB; Kirnbauer R
Vaccine; 2007 Mar; 25(11):2001-10. PubMed ID: 17239496
[TBL] [Abstract][Full Text] [Related]
30. Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.
Yang R; Wheeler CM; Chen X; Uematsu S; Takeda K; Akira S; Pastrana DV; Viscidi RP; Roden RB
J Virol; 2005 Jun; 79(11):6741-50. PubMed ID: 15890912
[TBL] [Abstract][Full Text] [Related]
31. Vaccination of healthy volunteers with human papillomavirus type 16 L2E7E6 fusion protein induces serum antibody that neutralizes across papillomavirus species.
Gambhira R; Gravitt PE; Bossis I; Stern PL; Viscidi RP; Roden RB
Cancer Res; 2006 Dec; 66(23):11120-4. PubMed ID: 17145854
[TBL] [Abstract][Full Text] [Related]
32. Detection of antibodies to a linear epitope on the major coat protein (L1) of human papillomavirus type-16 (HPV-16) in sera from patients with cervical intraepithelial neoplasia and children.
Cason J; Kambo PK; Best JM; McCance DJ
Int J Cancer; 1992 Feb; 50(3):349-55. PubMed ID: 1310487
[TBL] [Abstract][Full Text] [Related]
33. Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica.
Coseo S; Porras C; Hildesheim A; Rodriguez AC; Schiffman M; Herrero R; Wacholder S; Gonzalez P; Wang SS; Sherman ME; Jimenez S; Solomon D; Bougelet C; van Doorn LJ; Quint W; Safaeian M;
Sex Transm Dis; 2010 Nov; 37(11):706-14. PubMed ID: 20661178
[TBL] [Abstract][Full Text] [Related]
34. Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections.
Safaeian M; Porras C; Schiffman M; Rodriguez AC; Wacholder S; Gonzalez P; Quint W; van Doorn LJ; Sherman ME; Xhenseval V; Herrero R; Hildesheim A;
J Natl Cancer Inst; 2010 Nov; 102(21):1653-62. PubMed ID: 20944077
[TBL] [Abstract][Full Text] [Related]
35. Immunization with a consensus epitope from human papillomavirus L2 induces antibodies that are broadly neutralizing.
Tyler M; Tumban E; Dziduszko A; Ozbun MA; Peabody DS; Chackerian B
Vaccine; 2014 Jul; 32(34):4267-74. PubMed ID: 24962748
[TBL] [Abstract][Full Text] [Related]
36. Mutation Profile of HPV16 L1 and L2 Genes in Different Geographic Areas.
Tsakogiannis D; Nikolaidis M; Zagouri F; Zografos E; Kottaridi C; Kyriakopoulou Z; Tzioga L; Markoulatos P; Amoutzias GD; Bletsa G
Viruses; 2022 Dec; 15(1):. PubMed ID: 36680181
[TBL] [Abstract][Full Text] [Related]
37. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica.
Herrero R; Hildesheim A; Bratti C; Sherman ME; Hutchinson M; Morales J; Balmaceda I; Greenberg MD; Alfaro M; Burk RD; Wacholder S; Plummer M; Schiffman M
J Natl Cancer Inst; 2000 Mar; 92(6):464-74. PubMed ID: 10716964
[TBL] [Abstract][Full Text] [Related]
38. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of human papillomavirus type 16 in Sudanese women diagnosed with cervical carcinoma.
Elhasan LME; Bansal D; Osman OF; Enan K; Farag EABA
J Cancer Res Ther; 2019; 15(6):1316-1320. PubMed ID: 31898666
[TBL] [Abstract][Full Text] [Related]
40. Capsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approach.
Wu WH; Alkutkar T; Karanam B; Roden RB; Ketner G; Ibeanu OA
Virol J; 2015 Sep; 12():140. PubMed ID: 26362430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
